Indici bursieri Piețe bursiere Simboluri Statistici

Simbol OCGN
Ocugen Inc.

marți, 28 mai 2024, ora 19:28:28 EEST (UTC + 3)

Simbol OCGN
Simbol OCGN
Simbol eToro OCGN
MarketWatch OCGN
Finviz OCGN
Yahoo Finance OCGN
Google Finance OCGN
TradingView OCGN
Denumire Ocugen Inc.
Website ocugen.com
Piața NASDAQ
ISIN US67577C1053
Sector Health Technology
Industrie Biotechnology
Monedă USD
Preț 0,4669 USD
Capitalizare bursieră 0,106 mld. USD
P/E -1,28
Beta 1,9896
EPS -0,3642
Profit anual -79,14%
Dată actualizare 24.05.2023


Descriere
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.


Istoric cotații

Data P/E Beta Capitalizare Dividend EPS Profit anual Preț
04.11.2021 0,00 1,2231 2,530 0,00% -0,2653 +3.281,01% $0,00
24.05.2023 -1,28 1,9896 0,106 0,00% -0,3642 -79,14% $0,47



Pagină vizualizată de 70 ori și generată în 0,026451 secunde.